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Purpose: To determine the cross-linking effect of a riboﬂavin
ultraviolet-A (UV-A) corneal cross-linking treatment that is both
shorter and has lower energy than the Dresden protocol.
Methods: In a ﬁrst experiment, 12 human corneas were presoaked
with riboﬂavin and then irradiated with UV-A at 3 mW/cm2 after
clearing the surface of riboﬂavin, with no added riboﬂavin during
irradiation. Percent UV-A transmission through the corneas was
measured at intervals up to 30 minutes. A second experiment
involved 24 porcine corneas. Eight were de-epithelialized, presoaked
in riboﬂavin for 30 minutes, and irradiated at 1.5 mW/cm2 for
10 minutes. An additional 8 were riboﬂavin treated and similarly
irradiated, but with epithelium intact and a ﬁnal 8 corneas were not
treated. Young modulus was measured in all 24 corneas at the end of
the experiment.
Results: The ﬁrst experiment showed essentially complete
riboﬂavin oxidation after only 10 minutes. Based on these results,
a shortened UV-A exposure cross-linking experiment was de-
signed using a reduced UV-A ﬂuence of 1.5 mW/cm2, an
endothelial exposure within safety limits in humans. With this
protocol Young modulus was the same in the irradiated porcine
corneas but with epithelium intact as in the untreated corneas. In
contrast, Young modulus increased by a factor of 1.99 in the UV-A
cross-linked corneas at 1.5 mW/cm2 for 10 minutes with the
epithelium removed.
Conclusions: A shorter, lower energy protocol than the Dresden
protocol seems to provide a signiﬁcant increase in Young
modulus, similar to published results with higher energy, longer
exposure protocols.
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Corneal collagen cross-linking (CXL) as introduced in theDresden protocol1,2 has succeeded in reducing visual
loss in an increasing number of people worldwide. The
Bunsen–Roscoe Law suggests that the same cross-linking
effect could be completed in a shorter time as long as the
total ultraviolet (UV) irradiation energy is the same. Higher
intensity, shorter duration treatments have been tried, but
there have been safety and effectiveness questions with
these variations. Kymionis et al3 recently demonstrated that
the 30-minute, 3-mW/cm2 UV-A intensity Dresden protocol
CXL yielded a deeper corneal effect than a shorter, more
intense treatment of a 10-minute, 9-mW/cm2 CXL protocol,
casting some doubt on the application of the Bunsen–Roscoe
Law to cross-linking.
Studies on porcine eyes have shown toxicity to the
endothelium at irradiation levels of 0.35 mW/cm2 for 30 mi-
nutes.4 Based on the Lambert–Beer law of exponential decline
in UV transmission as a function of corneal depth, a recom-
mendation was derived, and it is now standard, that cross-
linking at 3 mW/cm2 should not be performed on corneas
thinner than 400 mm. Furthermore, to prevent endothelial
damage, there was a recommendation that a riboﬂavin layer be
renewed on the cornea during UV-A irradiation, but variations
in the thickness of the riboﬂavin covering layer over the
treatment time and over different treatments is a potential cause
of variation in the degree of cross-linking effect.
Two laboratory experiments, reported here, were con-
ducted to determine if it was possible to produce a shorter
duration, lower energy, time-variable UV intensity cross-
linking treatment that would accomplish the goal of ade-
quately increasing corneal stiffness while lowering the risk of
endothelial cell damage.
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MATERIALS AND METHODS
This research adhered to the tenets of the Declaration of
Helsinki. Institutional Review Board/Ethics Committee, and
Animal Care and Use committee approvals were obtained
(authorization no. 1269).
Riboflavin Solution
The solution used contained 0.1% wt/vol riboﬂavin-
5-phosphate and 15% (wt/vol) dextran T-500 (IROS, Naples,
Italy), similar to those typically used in the standard CXL
procedure described by the Dresden protocol.
Samples
Twelve human and 24 porcine corneas were used for
the experimental protocol. Human corneas, not suitable for
transplant because of biological contamination of the carrier
solution (Optisol GS; Bausch & Lomb, Rochester, NY), were
provided by the spin-off consortium Fast-linking Srl and by
the Pellegrini Hospital Regional Eye Bank.
The porcine corneas, harvested from a local slaughter-
house, were preserved with the same type of carrier solution
and were tested within 24 hours postmortem. All the samples
showed intact epithelium, a normal density of endothelial
cells, and absence of epithelial or stromal opacity. Before
experimentation, each cornea was excised circularly 2 mm
from the limbus, and the thickness (d) of the sample was
measured with a 5-mm resolution ultrasound pocket pachy-
meter (Quantel Medical, Clermont, France).
Spectrophotometric Measurements
The UV-A source used in this study (CF–X Linker
Modulated Megaride, IROS) uses light-emitting diodes with
a 370-nm wavelength and an intensity (i) varying from 1 to 10
mW/cm2. The distance between this device and the corneal
surface was set at 5 cm. The UV detector used was a Laser-
mate-Q laser (Coherent Inc, Santa Clara, CA), set orthogonal
to the radiation wave front. The detector has been previously
calibrated with a known intensity, so that standard error of the
mean was always within 60.01 mW/cm2. The UV-A
intensity values (i0) were measured placing the microscope
glass directly in contact with this device. The intensity of the
beam emerging from the posterior surface of every micro-
scope slide (i0) when exposed to UV-A (3 mW/cm2) was
previously measured; only slides presenting clear and un-
scratched glass and i0 values of 2.527 6 0.01 mW/cm2 were
used in this study. The speciﬁc absorbance value e of the
riboﬂavin solution was then measured using a spectrophotom-
eter (PerkinElmer Lambda 25 UV/Vis; PerkinElmer, Wal-
tham, MA); the starting solution was diluted to 1:20, to obtain
a molarity of 2.6 · 1023 mol/L. The test was repeated with 10
different samples. The i0 values at the posterior surface of
each corneal sample were initially measured, as described
above. These values at time 0 (t0) were used as a comparative
control for the subsequent readings. The cornea, with a 2-mm
ring of sclera (approximate) was then mounted on a modiﬁed
Franz-type diffusion cell (Ø 9 mm, 5-mL receptor volume;
SES GmbH- Analysesysteme, Bechenheim, Germany), with
the endothelium facing the receptor compartment. This
compartment was constituted with isotonic phosphate buffer
at pH 7.4 and was maintained at 37 6 1°C. When stipulated,
epithelium was removed using a surgical scraper and epithelial
melting by ethanol as already described.5 Before each exper-
iment, corneas were equilibrated with the use of 0.5-mL of
balanced salt solution for 10 minutes, after which 1.0 mL of
riboﬂavin solution was applied. After 30 minutes, cells were
dismantled, the excess donor solution was washed away with
balanced salt solution and the samples were set on the
microscope slide to be exposed to UV-A radiation. Human
corneas were divided into 2 groups. The ﬁrst group (H1, 6
samples) was soaked with the riboﬂavin solution after the
removal of the epithelium (Epi-off); the second group (H2, 6
samples) was soaked with intact epithelium (Epi-on). All the
samples were then placed on glass slides and were irradiated
for 30 minutes at 3 mW/cm2. The intensity of UV-A light
emerging from the posterior surface of each cornea (i0) was
measured every 5 minutes, with the last reading at 30 minutes.
Stress–Strain Measurements
Porcine corneas were divided into 3 groups of 8 samples
each. The ﬁrst group (P1) was not soaked with the riboﬂavin
solution after epithelium removal and was not exposed to UV-A
rays (baseline group). The second group (P2) was soaked with
the riboﬂavin solution, in Epi-on conditions, and received a 10-
minute UV-A exposure at 1.5 mW/cm2 (negative control
group). The third group (P3) was soaked with the riboﬂavin
solution, in Epi-off conditions, and received the same 10-minute
UV-A exposure at 1.5 mW/cm2. After irradiation, 2 strips of
each sample underwent static stress test measurements as
described below. All procedures were carried out while
shielding samples from external light sources. A previously
described experimental model was used for stress-strain mea-
surement.5 After CXL, 2 corneal strips of 5.0 6 0.2 mm width,
11.06 0.4 mm length (comprising 1 mm of sclera at both ends),
and 890 6 20 mm thickness were cut from each sample. The
dimensions of the corneal strips were assessed using a digital
caliper. Static stress-strain measurements were performed using
an electronic dynamometer (Ametek Lloyd Instruments LRX
plus, St. Clair Shores, MI). Young modulus was calculated at
2%, 4%, 6%, and 8% strain. The method used and the force
parameters were the same as previously described.4
Statistical Analysis
Statistical analyses were conducted using Graph-Pad
Prism (GraphPad Software Inc, San Diego, CA). Results are
given as mean 6 standard error of the mean. The signiﬁcance
of differences between groups was determined by one-way
analyses of variance followed by Bonferroni post hoc tests for
multiple comparisons. Differences with P , 0.05 were
considered statistically signiﬁcant in this study.
RESULTS
Transcorneal UV-A transmission data for the human
cadaver eyes are shown in Table 1 for the cases of cross-
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linking with epithelium removed. After riboﬂavin presoaking
for 30 minutes, those corneas with epithelium removed trans-
mitted only 24% of the UV-A light through the cornea (second
column), but after 5 minutes of UV-A irradiation fully 75% of
the UV-A light was transmitted (third column); both these were
statistically signiﬁcantly different from baseline (P , 0.05). In
the interval from 10 to 30 minutes after commencing
irradiation, 100% UV-A transmission was observed, within
the limits of statistical variation. There was no statistically
signiﬁcant difference between transmission from 10 to 30 mi-
nutes and baseline (P . 0.19 in all cases).
In the group where the epithelium was left intact, there
was no statistically signiﬁcant change in UV-A transmission
after riboﬂavin application for 30 minutes or after UV-A
exposure throughout the entire 30-minute period (P . 0.19 in
all cases, data not shown).
Table 2 shows the average values of Young modulus
measured at various levels of strain for the 3 test groups.
Group P3 demonstrated a statistically signiﬁcantly higher
Young modulus at 6% and 8% strain when compared with
groups P1 and P2 (P , 0.05). Although the average Young
modulus seemed slightly higher in group P2 than P1 at each
level of strain, the differences were not statistically signiﬁcant
(P . 0.05).
DISCUSSION
Spectroscopic results obtained in this study show that
the UV-A intensities emerging from the posterior surface of
the cornea during standard CXL procedures are not constant
over time, as suggested by the Lambert–Beer law. The
average intensity of UV-A radiation emerging from the
posterior corneal surface in the epithelium OFF group,
calculated immediately after topical riboﬂavin application,
was 0.27 6 0.041 mW/cm2, a value considered safe as it is
within the 0.35-mW/cm2 limit to avoid endothelial damage.4
However, by 10 minutes the apparent UV-A exposure
exceeded this safety limit in all tested corneas. These results
are consistent with those reported previously; several authors
have noted that during cross-linking, the endothelial UV light
dose would exceed safety limits.6,7 This is why the current
standard CXL protocol mandates the presence of a riboﬂavin
solution ﬁlm on the cornea during the CXL procedure, to
shield the endothelium from an excess of UV-A radiation.
There is a negative consequence to this; by reducing the
penetration of UV-A, the precorneal ﬁlm allows only the
cross-linking of the superﬁcial stroma, thus producing the so-
called “demarcation line” effect.8–10 Avoiding the use of the
precorneal riboﬂavin ﬁlm and lowering UV-A intensities
should provide a deeper biomechanical effect while main-
taining overall safety.
In addition, the results obtained in this study suggest
that the riboﬂavin has been oxidized long before the standard
UV-A irradiation period is complete. This implies that the
shielding fades long before the standard 30-minute UV-A
exposure ends. In the present study, the riboﬂavin shielding
effect completely disappeared in 10 minutes. As such,
a shorter irradiation time may be feasible, which would be
likely to produce a similar effect to the Dresden protocol with
lower potential UV-A exposure to the endothelium.
The differences between the groups in the second
experiment were most notable at 6% and 8% strain, which
is consistent with previous observations in the literature.5,11
Wollensak et al2 reported that the Young modulus of cross-
linked porcine corneas increased by a factor of 1.8–2.0 with
6% and 8% of strain. Our results are very similar, with
a corresponding increase of 1.7 and 2.2 times (Table 2) at
those levels of strain. We encountered some variation among
the porcine samples in measured values of stress at each strain
level. We attribute these variations in Young modulus to the
variations in porcine corneal thicknesses and to the fact that
only the outer stromal layers were cross-linked.5 However,
the SDs of our measurements were lower than those reported
in previous studies.5,11
The Dresden protocol for cross-linking has been
demonstrated to be effective in stabilizing keratoconus.1–5 It
requires a precorneal riboﬂavin ﬁlm and 30 minutes of UV-A
exposure, and it hardens the outer portion of the cornea.
Higher UV-A intensity and short-duration treatment produce
an even more superﬁcial effect and have the potential to
exceed published safety limits to endothelial irradiation.3,6,12
Experimental cross-linking in the present study, using
lower UV-A intensity and not adding riboﬂavin during UV
TABLE 1. Time-related (Minutes) UV-A Intensity Readings (mW/cm2) (i0) in Group H1 (Epi-off, i = 3 mW/cm2)
Before Riboﬂavin
Soaking (t0)
After 30 min of
Riboﬂavin Soaking
Time From the Beginning of the UV-A Irradiation (Commencing After Riboﬂavin Soaking)
5 min 10 min 15 min 20 min 25 min 30 min
Mean 1.14 0.27 0.85 1.1 1.1 1.09 1.09 1.07
SEM 0.04 0.02 0.02 0.04 0.04 0.05 0.05 0.03
P ,0.05 ,0.05 0.41 0.42 0.38 0.43 0.19
Epi, epithelium; P, signiﬁcance with respect to t0 values; SEM, standard error of the mean.
TABLE 2. Measured Young Modulus (E) at 2%, 4%, 6%, and
8% Strain in Porcine Corneas
Group
Average E Values 6 SEM
2% Strain 4% Strain 6% Strain 8% Strain
P1 0.43 6 0.17 1.07 6 0.30 3.10 6 0.32 7.07 6 0.69
P2 0.71 6 0.32 1.22 6 0.28 3.42 6 0.36 7.48 6 0.82
P3 0.92 6 0.27 1.58 6 0.39 6.79 6 0.61* 12.15 6 0.88*
Values are expressed in mega-Pascals.
*P , 0.05 for group P3 at 6% and 8% of strain compared with group P2 and P1.
SEM, standard error of the mean.
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irradiation, provided corneal stiffening similar to that achieved
with the Dresden protocol. These effects were achieved with
a 10-minute exposure time, stopping the treatment once the
riboﬂavin has already oxidized. This suggests that a quicker,
safer, and more reproducible cross-linking protocol may
be viable.
The experimental data reported here, along with
additional experimental results, are being used to develop
a mathematical model describing the rate of photolysis of
riboﬂavin by unit of volume (rate equation). It is hoped that
such a model may allow for a UV-A energy optimization,
further reducing unnecessary UV-A exposure. That material
will be the subject of a separate article.
Associated clinical data related to the shorter protocol
have been collected and recently published. Results in the
clinical study demonstrate that stabilization of corneal and
refractive parameters can be achieved with the shorter, lower
energy protocol.13
The results of 2 laboratory experiments, reported here,
indicate that the Lambert–Beer law must be modiﬁed in cross-
linking to account for the reduction in UV ﬁltration over time.
They also suggest that it may be possible to produce a shorter
duration, lower energy, time-variable UV-A intensity cross-
linking treatment that will accomplish the goal of adequately
increasing corneal stiffness while lowering the risk of endo-
thelial cell damage. Such a treatment would not require
a precorneal riboﬂavin ﬁlm during UV-A exposure. A new
CXL protocol based on these ﬁndings may yield a safer,
equally effective, more reproducible, and more rapid cross-
linking treatment. It must be kept in mind that the results
presented here are based on in vitro experiments and cannot be
generalized to in vivo experiments. Preliminary results have
been obtained with the procedure in a clinical setting, but only
cases of mild keratoconus were treated.13 Additional clinical
research is required to determine if the procedure studied here
can be generalized to broader clinical application.
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